Pancreatic cancer carries a poor prognosis and relies on endoscopic ultrasound (EUS) for targeted biopsy and radiotherapy. However, the speckle noise, low contrast, and unintuitive appearance of EUS make segmentation of pancreatic tumors with fully supervised deep learning (DL) models both error-prone and dependent on large, expert-curated annotation datasets. To address these challenges, we present TextSAM-EUS, a novel, lightweight, text-driven adaptation of the Segment Anything Model (SAM) that requires no manual geometric prompts at inference. Our approach leverages text prompt learning (context optimization) through the BiomedCLIP text encoder in conjunction with a LoRA-based adaptation of SAM's architecture to enable automatic pancreatic tumor segmentation in EUS, tuning only 0.86% of the total parameters. On the public Endoscopic Ultrasound Database of the Pancreas, TextSAM-EUS with automatic prompts attains 82.69% Dice and 85.28% normalized surface distance (NSD), and with manual geometric prompts reaches 83.10% Dice and 85.70% NSD, outperforming both existing state-of-the-art (SOTA) supervised DL models and foundation models (e.g., SAM and its variants). As the first attempt to incorporate prompt learning in SAM-based medical image segmentation, TextSAM-EUS offers a practical option for efficient and robust automatic EUS segmentation.

In data-scarce scenarios, deep learning models often overfit to noise and irrelevant patterns, which limits their ability to generalize to unseen samples. To address these challenges in medical image segmentation, we introduce Diff-UMamba, a novel architecture that combines the UNet framework with the mamba mechanism to model long-range dependencies. At the heart of Diff-UMamba is a noise reduction module, which employs a signal differencing strategy to suppress noisy or irrelevant activations within the encoder. This encourages the model to filter out spurious features and enhance task-relevant representations, thereby improving its focus on clinically significant regions. As a result, the architecture achieves improved segmentation accuracy and robustness, particularly in low-data settings. Diff-UMamba is evaluated on multiple public datasets, including medical segmentation decathalon dataset (lung and pancreas) and AIIB23, demonstrating consistent performance gains of 1-3% over baseline methods in various segmentation tasks. To further assess performance under limited data conditions, additional experiments are conducted on the BraTS-21 dataset by varying the proportion of available training samples. The approach is also validated on a small internal non-small cell lung cancer dataset for the segmentation of gross tumor volume in cone beam CT, where it achieves a 4-5% improvement over baseline.

The emergence of Vision Transformers (ViTs) has revolutionized computer vision, yet their effectiveness compared to traditional Convolutional Neural Networks (CNNs) in medical imaging remains under-explored. This study presents a comprehensive comparative analysis of CNN and ViT architectures across three critical medical imaging tasks: chest X-ray pneumonia detection, brain tumor classification, and skin cancer melanoma detection. We evaluated four state-of-the-art models - ResNet-50, EfficientNet-B0, ViT-Base, and DeiT-Small - across datasets totaling 8,469 medical images. Our results demonstrate task-specific model advantages: ResNet-50 achieved 98.37% accuracy on chest X-ray classification, DeiT-Small excelled at brain tumor detection with 92.16% accuracy, and EfficientNet-B0 led skin cancer classification at 81.84% accuracy. These findings provide crucial insights for practitioners selecting architectures for medical AI applications, highlighting the importance of task-specific architecture selection in clinical decision support systems.

This investigation delves into the diagnosis of COVID-19, using X-ray images generated by way of an effective deep learning model. In terms of assessing the COVID-19 diagnosis learning model, the methods currently employed tend to focus on the accuracy rate level, while neglecting several significant assessment parameters. These parameters, which include precision, sensitivity and specificity, significantly, F1-score, and ROC-AUC influence the performance level of the model. In this paper, we have improved the InceptionResNet and called Enhanced InceptionResNet with restructured parameters termed, "Enhanced InceptionResNet," which incorporates depth-wise separable convolutions to enhance the efficiency of feature extraction and minimize the consumption of computational resources. For this investigation, three residual network (ResNet) models, namely Res- Net, InceptionResNet model, and the Enhanced InceptionResNet with restructured parameters, were employed for a medical image classification assignment. The performance of each model was evaluated on a balanced dataset of 2600 X-ray images. The models were subsequently assessed for accuracy and loss, as well subjected to a confusion matrix analysis. The Enhanced InceptionResNet consistently outperformed ResNet and InceptionResNet in terms of validation and testing accuracy, recall, precision, F1-score, and ROC-AUC demonstrating its superior capacity for identifying pertinent information in the data. In the context of validation and testing accuracy, our Enhanced InceptionRes- Net repeatedly proved to be more reliable than ResNet, an indication of the former's capacity for the efficient identification of pertinent information in the data (99.0% and 98.35%, respectively), suggesting enhanced feature extraction capabilities. The Enhanced InceptionResNet excelled in COVID-19 diagnosis from chest X-rays, surpassing ResNet and Default InceptionResNet in accuracy, precision, and sensitivity. Despite computational demands, it shows promise for medical image classification. Future work should leverage larger datasets, cloud platforms, and hyperparameter optimisation to improve performance, especially for distinguishing normal and pneumonia cases.

Pancreatic cancer carries a poor prognosis and relies on endoscopic ultrasound (EUS) for targeted biopsy and radiotherapy. However, the speckle noise, low contrast, and unintuitive appearance of EUS make segmentation of pancreatic tumors with fully supervised deep learning (DL) models both error-prone and dependent on large, expert-curated annotation datasets. To address these challenges, we present TextSAM-EUS, a novel, lightweight, text-driven adaptation of the Segment Anything Model (SAM) that requires no manual geometric prompts at inference. Our approach leverages text prompt learning (context optimization) through the BiomedCLIP text encoder in conjunction with a LoRA-based adaptation of SAM's architecture to enable automatic pancreatic tumor segmentation in EUS, tuning only 0.86% of the total parameters. On the public Endoscopic Ultrasound Database of the Pancreas, TextSAM-EUS with automatic prompts attains 82.69% Dice and 85.28% normalized surface distance (NSD), and with manual geometric prompts reaches 83.10% Dice and 85.70% NSD, outperforming both existing state-of-the-art (SOTA) supervised DL models and foundation models (e.g., SAM and its variants). As the first attempt to incorporate prompt learning in SAM-based medical image segmentation, TextSAM-EUS offers a practical option for efficient and robust automatic EUS segmentation. Code is available at https://github.com/HealthX-Lab/TextSAM-EUS .

The integration of artificial intelligence (AI) into medical image analysis has transformed healthcare, offering unprecedented precision in diagnosis, treatment planning, and disease monitoring. However, its adoption within the Internet of Medical Things (IoMT) raises significant challenges related to transparency, trustworthiness, and security. This paper introduces a novel Explainable AI (XAI) framework tailored for Medical Cyber-Physical Systems (MCPS), addressing these challenges by combining deep neural networks with symbolic knowledge reasoning to deliver clinically interpretable insights. The framework incorporates an Enhanced Dynamic Confidence-Weighted Attention (Enhanced DCWA) mechanism, which improves interpretability and robustness by dynamically refining attention maps through adaptive normalization and multi-level confidence weighting. Additionally, a Resilient Observability and Detection Engine (RODE) leverages sparse observability principles to detect and mitigate adversarial threats, ensuring reliable performance in dynamic IoMT environments. Evaluations conducted on benchmark datasets, including CheXpert, RSNA Pneumonia Detection Challenge, and NIH Chest X-ray Dataset, demonstrate significant advancements in classification accuracy, adversarial robustness, and explainability. The framework achieves a 15% increase in lesion classification accuracy, a 30% reduction in robustness loss, and a 20% improvement in the Explainability Index compared to state-of-the-art methods.

The rapid advancement of artificial intelligence (AI) in healthcare has accelerated innovations in medical algorithms, yet its broader adoption faces critical ethical and technical barriers. A key challenge lies in algorithmic bias stemming from heterogeneous medical data across institutions, equipment, and workflows, which may perpetuate disparities in AI-driven diagnoses and exacerbate inequities in patient care. While AI's ability to extract deep features from large-scale data offers transformative potential, its effectiveness heavily depends on standardized, high-quality datasets. Current standardization gaps not only limit model generalizability but also raise concerns about reliability and fairness in real-world clinical settings, particularly for marginalized populations. Addressing these urgent issues, this paper proposes an ethical AI framework centered on a novel self-supervised medical image standardization method. By integrating self-supervised image style conversion, channel attention mechanisms, and contrastive learning-based loss functions, our approach enhances structural and style consistency in diverse datasets while preserving patient privacy through decentralized learning paradigms. Experiments across multi-institutional medical image datasets demonstrate that our method significantly improves AI generalizability without requiring centralized data sharing. By bridging the data standardization gap, this work advances technical foundations for trustworthy AI in healthcare.

Early detection and precise preoperative staging of early gastric cancer (EGC) are critical. Therefore, this study aims to develop a deep learning model using portal venous phase CT images to accurately distinguish EGC without lymph node metastasis. This study included 3164 patients with gastric cancer (GC) who underwent radical surgery at two medical centers in China from 2006 to 2019. Moreover, 2.5D radiomic data and multi-instance learning (MIL) were novel approaches applied in this study. By basing the selection of features on 2.5D radiomic data and MIL, the ResNet101 model combined with the XGBoost model represented a satisfactory performance for diagnosing pT1N0 GC. Furthermore, the 2.5D MIL-based model demonstrated a markedly superior predictive performance compared to traditional radiomics models and clinical models. We first constructed a deep learning prediction model based on 2.5D radiomics and MIL for effectively diagnosing pT1N0 GC patients, which provides valuable information for the individualized treatment selection.

Breast cancer (BC) remains one of the leading causes of cancer-related mortality among women, despite recent advances in Computer-Aided Diagnosis (CAD) systems. Accurate and efficient interpretation of multi-view mammograms is essential for early detection, driving a surge of interest in Artificial Intelligence (AI)-powered CAD models. While state-of-the-art multi-view mammogram classification models are largely based on Transformer architectures, their computational complexity scales quadratically with the number of image patches, highlighting the need for more efficient alternatives. To address this challenge, we propose Mammo-Mamba, a novel framework that integrates Selective State-Space Models (SSMs), transformer-based attention, and expert-driven feature refinement into a unified architecture. Mammo-Mamba extends the MambaVision backbone by introducing the Sequential Mixture of Experts (SeqMoE) mechanism through its customized SecMamba block. The SecMamba is a modified MambaVision block that enhances representation learning in high-resolution mammographic images by enabling content-adaptive feature refinement. These blocks are integrated into the deeper stages of MambaVision, allowing the model to progressively adjust feature emphasis through dynamic expert gating, effectively mitigating the limitations of traditional Transformer models. Evaluated on the CBIS-DDSM benchmark dataset, Mammo-Mamba achieves superior classification performance across all key metrics while maintaining computational efficiency.

<b>BACKGROUND</b>. Coronary artery calcium (CAC) scoring is used to stratify acute coronary syndrome (ACS) risk. Nonetheless, patients with a CAC score of zero (CAC₀) remain at risk from noncalcified plaque components. <b>OBJECTIVE</b>. The purpose of this study was to explore CTA-derived coronary artery plaque characteristics in symptomatic patients with CAC₀ who subsequently have ACS through comparisons with patients with a CAC score greater than 0 (CAC_{> 0}) who subsequently have ACS as well as with patients with CAC₀ who do not subsequently have ACS. <b>METHODS</b>. This study entailed a secondary retrospective analysis of prior prospective registry data. The international multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry collected longitudinal observational data on symptomatic patients who underwent clinically indicated coronary CTA from January 2004 to May 2010. ICONIC (Incident Coronary Syndromes Identified by CT) was a nested cohort study conducted within CONFIRM that identified patients without known coronary artery disease (CAD) at the time of CTA who did and did not subsequently have ACS (i.e., the ACS and control groups, respectively) and who were propensity matched in a 1:1 ratio on the basis of CAD risk factors and CAD severity on CTA. The present ICONIC substudy selected matched patients in the ACS and control groups who both had documented CAC scores. CTA examinations were analyzed using artificial intelligence software for automated quantitative plaque assessment. In the ACS group, invasive angiography findings were used to identify culprit lesions. <b>RESULTS</b>. The present study included 216 patients (mean age, 55.6 years; 91 women and 125 men), with 108 patients in each of the ACS and control groups. In the ACS group, 23% (<i>n</i> = 25) of patients had CAC₀. In the ACS group, culprit lesions in the subsets of patients with CAC₀ and CAC_{> 0} showed no significant differences in fibrous, fibrofatty, or necrotic-core plaque volumes (<i>p</i> > .05). In the CAC₀ subset, patients with ACS, compared with control patients, had greater mean (± SD) fibrous plaque volume (29.4 ± 42.0 vs 5.5 ± 15.2 mm³, <i>p</i> < .001), fibrofatty plaque volume (27.3 ± 52.2 vs 1.3 ± 3.7 mm³, <i>p</i> < .001), and necrotic-core plaque volume (2.8 ± 6.4 vs 0.0 ± 0.1 mm³, <i>p</i> < .001). <b>CONCLUSION</b>. After propensity-score matching, 23% of patients with ACS had CAC₀. Patients with CAC₀ in the ACS and control groups showed significant differences in volumes of noncalcified plaque components. <b>CLINICAL IMPACT</b>. Methods that identify and quantify noncalcified plaque forms may help characterize ACS risk in symptomatic patients with CAC₀.